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Background 
• Current AUA guidelines recommend a single 
dose of fluoroquinolones (FQs) or 
cephalosporins prior to transrectal prostate 
biopsy. 
• FQs are standard in the prophylaxis of 
transrectal prostate biopsies; however, they 
have come under scrutiny as a result of 
increasing resistance and FDA Black Box 
warnings. 
Objectives 
• To evaluate peri-procedural antibiotic 
prophylaxis regimens based on pre-
procedural rectal swab cultures. 
• To evaluate infection rates between 
transrectal biopsy patients receiving FQs 
alone and those receiving ceftriaxone or 
gentamicin in addition to FQs.   
Materials and Methods 
• Retrospective study of a cohort of 274 males 
between age 43-86, undergoing Transrectal 
Ultrasound (TRUS) guided Prostate Biopsy 
between 8/2016 to 3/2017  
• Post-biopsy infection defined as fever or 
confirmed urinary tract infection within 2 
weeks of biopsy 
• Cohort was also subdivided into groups 
receiving standard antibiotic prophylaxis with 
Ciprofloxacin or augmented antibiotic 
prophylaxis with Ciprofloxacin AND 
Ceftriaxone, Gentamicin, or Zosyn 
Results 
• 274 males ages 43-86 (median 65) underwent 
TRUS biopsy.  30 underwent pre-biopsy rectal 
swab, 0 infections.  9 patients without rectal 
swab cultures had post biopsy infections 
(3.7%).  (Figure 1) 
• 131 patients received standard antibiotic 
regimen, 5 had post biopsy infection (3.8%).  
143 patients received augmented antibiotic 
regimen, 4 had post biopsy infection (2.8%).       
(Figure 2) 
Conclusions & Limitations 
• A trend toward decreased infection rates in 
augmented prophylaxis as compared to 
fluoroquinolones alone 
• Retrospective data collection on a small 
sample size 
• Lack of standardized antibiotic prophylaxis 
protocol 
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Figure 2. Graph comparing rates of infection in patients who received Cipro only vs. those 
who received an augmented antibiotic regimen for pre-procedural prophylaxis.  P = 0.64, Chi 
Square = 0.21, 95% CI 
Future Implementation 
• Standardized rectal swab and pre-procedural 
prophylaxis protocol 
• Prospective data collection and cost benefit 
analysis of rectal swab-guided prophylaxis vs. 
standard prophylaxis regimen 
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Figure 1.  Graph comparing infection rates in those who underwent pre-biopsy rectal 
swab, and those who did not.  P = 0.89, Chi Square = 0.02, 95% CI 
 
Demographics Immunocompromised 
      Total 55 20.1% 
Age Range 43-86   Swab 4 7.3% 
Median Age 65   w/o Swab 51 92.7% 
Total # Patients 274   Infection     
Rectal Swab     Total 9 3.3% 
Swab 30 10.9% Swab 0 0.0% 
No Swab 244 89.1% w/o Swab 9 3.7% 
Resistant Cultures   Rate of Infection by Antibiotic 
FQ resistant 7 23.3% Cipro Only 5/131 3.8% 
No Resistance 23 76.7% Augmented 4/143 2.8% 
